Cingulate Inc. Share Price
CINGCingulate Inc. Stock Performance
Open $4.93 | Prev. Close $4.67 | Circuit Range N/A |
Day Range $4.87 - $5.20 | Year Range $3.23 - $11.78 | Volume 7,334 |
Average Traded $5.06 |
Cingulate Inc. Share Price Chart
About Cingulate Inc.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Apr-26 | $4.66 | $4.67 | -0.21% |
28-Apr-26 | $5.29 | $4.68 | -11.36% |
27-Apr-26 | $5.35 | $5.28 | -2.94% |
24-Apr-26 | $5.73 | $5.44 | -3.29% |
23-Apr-26 | $5.62 | $5.63 | +0.18% |
22-Apr-26 | $5.70 | $5.62 | -4.34% |
21-Apr-26 | $5.90 | $5.87 | -2.98% |
FAQs on Cingulate Inc. Share Price
Can I buy Cingulate Inc. shares in India?
What is the share price of Cingulate Inc.?
What is the 5 year returns of Cingulate Inc.?
What are the high & low stock price of Cingulate Inc. today?
What is the 52-week high and low of Cingulate Inc. stock?